QCM
ABUS icon

Quantinno Capital Management’s Arbutus Biopharma ABUS Stock Holding History

Quantinno Capital Management’s Portfolio ABUS Stock Details ABUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$219K Sell
48,715
-5,950
-11% -$26K ﹤0.01% 3176
2025
Q4 		$263K Buy
54,665
+18,769
+52% +$84.4K ﹤0.01% 2908
2025
Q3 		$163K Buy
+35,896
New +$132K ﹤0.01% 2813

Other funds holding ABUS

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
WCM
Whitefort Capital Management New York $339M AUM 52.48% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Quantinno Capital Management's ABUS Position: Q1 2026 in Review

Quantinno Capital Management reduced its Arbutus Biopharma (ABUS) stake by 11% in Q1 2026, selling an estimated $26K and leaving 48,715 shares worth $219K. The position accounts for ﹤0.01% of the portfolio, ranked #3176.

Quantinno Capital Management first reported a position in ABUS in Q3 2025 and has held it in 3 quarters since. The position peaked at $263K in Q4 2025. 167 funds tracked by Wall St. Rank hold ABUS as of Q1 2026.

  • Quantinno Capital Management held 48,715 shares of Arbutus Biopharma worth $219K as of Q1 2026.
  • Quantinno Capital Management sold 5,950 Arbutus Biopharma shares in Q1 2026, an estimated $26K.
  • Arbutus Biopharma made up ﹤0.01% of Quantinno Capital Management's portfolio in Q1 2026, its #3176 holding.
  • Quantinno Capital Management first reported a position in Arbutus Biopharma in Q3 2025 and has held it in 3 quarters since.
  • Quantinno Capital Management's Arbutus Biopharma position peaked at $263K in Q4 2025.
  • 167 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q1 2026.

Based on Quantinno Capital Management's 13F filing for Q1 2026, filed 15 May 2026.